Development

A CRISPR nasal spray edits influenza in the lungs

development2026-01-06

Claim

Australian researchers are developing a CRISPR Cas13 nasal spray that edits influenza RNA directly in the lungs.

Reporting date: (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Knowledge graphopen in browser →

Reported in
Evidence for
Referenced by

Cite or correct this record

Suggest a correction — opens a GitHub draft for you to review and submit.